Clinical Trial Update: Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating axitinib in combination with avelumab for recurrent or metastatic adenoid cystic carcinoma has completed enrollment with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• BAVENCIO (AVELUMAB)
• INLYTA (AXITINIB)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Adenoid Cystic Carcinoma, Progressive Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-08-26